MTOR and melanoma: Syed et al. reported that fisetin targeted several key melanomagenesis markers by diverse mechanisms, including inhibition of the Akt/RSK/mTOR/S6K axis, suggesting that fisetin is a potent anti-melanoma agent [68,139,140].